Lucy Chambers

Download

Biography

Lucy Chambers

Lucy Chambers is counsel in Weil’s Antitrust practice.

She advises on all aspects of EU and UK competition law, including merger control, cartel investigations, restrictive practices, market dominance, and general counselling and compliance.   Her experience covers antitrust and regulatory proceedings before the European Commission, EU member states, the UK CMA and other key regulators globally.  In particular, she has significant experience on various high profile, complex and multi-jurisdictional M&A transactions, with a particular focus on cross-border merger control and foreign investment reviews.

Lucy’s experience encompasses a broad range of industries, including technology and digital markets, AI, energy and defence, pharmaceuticals, financial services, media, telecommunications, consumer goods, aviation, life sciences, and industrial/manufacturing sectors. Prior to joining Weil, Lucy was a senior associate at a Magic Circle firm.

Lucy is involved in American Bar Association Antitrust Section as a vice-Chair of the International Committee and an editor of the Antitrust Law Developments textbook.

Lucy is a Tutor at Oxford University, where she tutors the undergraduate Competition Law and Policy course at the Faculty of Law.

Representative experience at Weil and from her previous firm includes:

  • Microsoft on the OpenAI recapitalisation and restructuring into a Public Benefit Corporation
  • Microsoft on the CMA and European Commission investigation into Microsoft’s partnership with OpenAI
  • Microsoft on the CMA study into AI Foundation Models
  • Microsoft on the merger control aspects of its investment in Mistral AI
  • OCS Group on the national security aspects of its £3.1 billion recommended offer for Mitie Group plc
  • Goldman Sachs Alternatives on the acquisition of a majority stake in NAVEX
  • CBIZ, Inc. on its $5 billion sale to Grant Thornton Advisors LLC
  • Sanofi on its $9.5 billion acquisition of Blueprint Medicines
  • Sanofi on its $2.2 billion acquisition of Dynavax Technologies
  • Antitrust, FDI and merger control aspects of the First Brands restructuring
  • Merger control and FDI analysis for Nicklaus Companies LLC in the sale of substantially all of its assets pursuant to section 363 of the Bankruptcy Code
  • PAI Partners on the acquisition of Food Union by Froneri (a joint venture between PAI and Nestle)
  • Richemont International on the merger control and foreign investment aspects of the joint venture between Yoox Net-a-Porter and Farfetch
  • clients in various sectors during Article 101 and Article 102 investigations before the European Commission, including Sabre Corporation in the airline ticket distribution investigation
  • S&P Global on the merger control and foreign investment aspects of its acquisition of IHS Markit
  • Korean Airlines on the UK merger control aspects of its acquisition of Asiana Airlines
  • Warner Music Group on the CMA market study into music and streaming
  • Sabre Corporation on the merger control aspects and subsequent CAT appeal relating to its attempted acquisition of Farelogix, Inc.
  • Tata Steel Limited on the merger control aspects of its attempted joint venture with ThyssenKrupp
  • Thermo Fisher Scientific, Inc. on merger control aspects of its $7.2 billion acquisition of Patheon
  • Koninklijke Philips NV on follow-on damages litigation following the Smart Card Chip cartel

Awards and Recognition, Speaking Engagements, Guides and Resources, Latest Thinking, Firm News & Announcements

Latest Thinking

View all

Firm News & Announcements